GlassScriptPhysician profile
Jeffrey J Visco
NPI 1902885601
$4,114.24
in general payments reported to CMS, 2019-2025
23 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,285 · 2020: $309 · 2021: $269 · 2022: $390 · 2023: $351 · 2024: $292 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,929.15 | 2019-2020 | |
| Axonics, INC. | $288.32 | 2020-2024 | Axonics |
| Thd America, INC. | $248.95 | 2021-2025 | |
| Medtronic, INC. | $238.72 | 2023-2024 | Progrip |
| Boston Scientific Corporation | $206.53 | 2022 | |
| Biom'Up Sa | $175.54 | 2019 | |
| Conmed Corporation | $161.13 | 2020-2025 | Airseal |
| Smith+Nephew, INC. | $153.22 | 2022 | |
| Medtronic USA, INC. | $117.37 | 2019 | |
| Ethicon US, LLC | $111.01 | 2024 | Vistaseal, Ethicon, Echelon Flex |
| Exact Sciences Corporation | $90.61 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $75.08 | 2021-2024 | Rinvoq |
| Nevro Corp. | $55.16 | 2019 | |
| Braintree Laboratories, INC. | $39.04 | 2021-2023 | Sutab, Suflave |
| Fujifilm Healthcare Americas Corporation | $36.18 | 2023-2024 | Fujifilm |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $32.29 | 2020 | |
| Hollister Incorporated | $30.02 | 2022 | |
| Acera Surgical, INC. | $29.13 | 2025 | Restrata Wound Matrix |
| Suture Ease, INC. | $26.99 | 2019 | |
| Shire North American Group INC | $24.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.89 | 2023 | Rebyota |
| Coloplast Corp | $14.98 | 2025 | |
| Janssen Biotech, INC. | $12.76 | 2023 | Stelara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Visco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.